proportion of HIV-infected individuals who are unaware of their status, the common occurrence of late diagnosis with advanced disease progression, and the consistently high number of incident cases of HIV infection that are reported annually despite extensive prevention efforts. An estimated 25% of individuals living with HIV infection in the United States are unaware of their HIV infection status [2] . Furthermore, late presentation is frequently observed, with more than onehalf of patients with newly diagnosed infection entering care with initial CD4 + cell counts !200 cells/mm 3 [3] [4] [5] [6] [7] . The updated recommendations aim to reduce the number of infected persons who are unaware of their infection status and to facilitate earlier diagnosis of HIV infection [1] , which may ultimately benefi the health of individuals, as well as the public health, through reduced transmission and a reduction in the number of secondary infections.
Dramatic increases in the number of individuals in need of HIV treatment are anticipated in response to the implementation of the updated CDC HIV testing recommendations [8, 9] . The recommendations emphasize the importance of linkage to clinical and preventive services for patients with newly diagnosed infection [1] . Studies show that 20%-40% of patients with recently diagnosed HIV infection do not attend an outpatient clinic visit within 6 months after receipt of their diagnosis [10, 11] . Among those who successfully initiate outpatient care, missed visits and loss to follow-up during the year after attending a firs HIV clinic visit are common and are associated with delays in the receipt of antiretroviral medications [7, 12, 13] . However, to our knowledge, no published study has evaluated the relationship between missed visits in the firs year of HIV care and long-term survival. We hypothesized that patients who missed visits in the year after establishing outpatient HIV treatment would have higher subsequent mortality in the context of other baseline sociodemographic, psychosocial, and clinical factors that are associated with survival.
PATIENTS AND METHODS
Cohort description. The University of Alabama at Birmingham (UAB) 1917 HIV/AIDS Clinic Cohort Observational Database Project (UAB 1917 Clinic Cohort) is described in detail elsewhere [14] [15] [16] . Here, we conduct a retrospective cohort study nested in the UAB 1917 Clinic Cohort to evaluate the impact of missed visits on long-term survival among patients establishing initial outpatient HIV treatment.
Eligibility criteria. Patients who attended an initial primary HIV care visit at the UAB 1917 Clinic from 1 January 2000 through 31 December 2005 and had received no prior outpatient HIV treatment at another facility were included in this analysis. Medical records of patients attending a f rst visit at the UAB 1917 Clinic during the study period were reviewed independently by 2 abstractors (J.S.R. and S.A.) to determine whether a patient had previously received HIV treatment elsewhere and was therefore ineligible for study participation. Discrepancies in reporting (!2% of records) were arbitrated by 2 physician HIV care providers at the UAB 1917 Clinic (M.J.M. and J.H.W.). These criteria were employed because of our interest in studying a homogeneous sample of patients who were establishing initial outpatient HIV treatment, while excluding patients who had previously received care at other facilities (who represent a different sample group). We were interested in evaluating the impact of missed visits within the fir t year after establishing care (exposure) on long-term survival (outcome); therefore, patients who died within 1 year after their initial visit were excluded from analyses, because they did not have appointment attendance data for the entire exposure period.
Measures. Appointment attendance during the fi st year after establishing outpatient care was the primary independent variable of interest. Missed visit status was determined for all study participants by evaluating appointment attendance records for 365 days after an initial attended primary HIV care visit. Urgent care and subspecialty visits (e.g., dermatology) at the clinic were excluded. Appointment status at the UAB 1917 Clinic is managed with a Web-based software program that is updated daily. Consistent with previous studies [17] [18] [19] [20] , only missed visits for which a patient did not call the clinic to cancel or reschedule (i.e., "no show" visits) were included in the missed visit measure. Appointments that were cancelled by the clinic, those that a patient called to cancel in advance, or those that were cancelled because the patient was hospitalized are not included in the missed visit measure. Missed visit status was recorded as a dichotomous measure, with patients characterized as having no missed visits or у1 missed visit during the f rst year of outpatient HIV treatment.
Other covariates were selected a priori and included sociodemographic (age, sex, race, HIV risk group, and insurance status), psychosocial (affective mental health, substance abuse, and alcohol abuse disorders), and clinical measures (baseline CD4 + cell count, plasma HIV RNA level, and receipt of antiretroviral therapy during the firs year of care). All measures were determined by query of the UAB 1917 Clinic Cohort Database, which includes psychosocial measures that are captured from diagnosis lists in patients' medical records. All cause mortality, which was the primary outcome measure, was ascertained by an electronic query of the Social Security Death Index performed on 1 August 2007.
Statistical analysis. Descriptive statistics were performed for all study variables to evaluate distributions and to ensure that assumptions of statistical tests to be used were met. Unadjusted analyses using x2 tests and logistic regression and multivariable logistic regression analysis controlling for the aforementioned covariates were used to evaluate factors associated with missing a primary HIV care clinic visit during the firs year after establishing initial outpatient care. The discriminative capacity and fi of the multivariable model were assessed by the C-statistic and Hosmer-Lemeshow goodness-of-fi test, respectively.
A Kaplan-Meier plot was used to evaluate long-term survival among patients according to missed visit status during the fi st year of outpatient HIV care. Unadjusted and adjusted Cox proportional hazards models were used to evaluate factors associated with long-term survival. Because of the relatively modest number of deaths relative to the number of covariates in the primary Cox model, a sensitivity analysis was conducted that used propensity score methods [21] . In brief, a propensity score for "missed visit" was determined for all study participants with use of the multivariable logistic regression model to evaluate missed visit status in the year of HIV treatment. This approach serves to combine covariates into a single propensity score and thereby reduces the number of variables and addresses potential concerns of model over-fitting Next, a Cox proportional hazards model was used to evaluate the relationship between missed visit status and long-term survival while adjusting for propensity score and for antiretroviral medication receipt during the firs year of treatment. All analyses were conducted using SAS, version 9.0 (SAS). P values !.05 were considered to be statistically significant
RESULTS
During the study period, 567 (49%) of 1165 patients who attended a firs primary HIV care visit at the UAB 1917 Clinic had not previously received HIV care elsewhere and were establishing initial outpatient HIV treatment. Twenty-four patients (4%) died within 1 year after their initial visit, leaving 543 patients who were included in statistical analyses. The sociodemographic, psychosocial, and clinical characteristics of the study sample (543 patients) were largely similar to those of the overall population (1165 patients) (data not shown). Among the 543 study participants, 325 patients (60%) had a missed visit within the firs year of care (mean no. of missed , ), whereas 218 patients (40%) attended visits ‫ע‬ SD 1.8 ‫ע‬ 1.1 all scheduled appointments. Thirty-two (10%) of the patients with missed visits and 10 (5%) of the patients with perfect appointment attendance died during longitudinal follow-up (figu e 1). Among the 325 patients with missed visits within the firs year of care, a similar mean number of missed visits (‫ע‬SD) were observed among the 32 patients who died ( missed visits) and the 293 patients who survived 1.9 ‫ע‬ 1.6 ( missed visits) during follow-up.
The baseline characteristics of the 543 study participants in-clude a mean age (‫ע‬SD) of years; 25% of the patients 37.7 ‫ע‬ 9.4 were female, and 54% were black (table 1) . The HIV risk group was men who have sex with men in 52% of the patients, heterosexual transmission in 40%, and injection drug use in 8%. At initial presentation for care, one-half of the study patients lacked private health insurance (15% had public insurance, and 35% were uninsured). Affective mental health, substance abuse, and alcohol abuse disorders were documented in 48%, 26%, and 20% of patients, respectively. The mean (‫ע‬SD) baseline HIV RNA load was log 10 copies/mL; 38% of patients 4.4 ‫ע‬ 1.1 had a baseline CD4 + cell count !200 cells/mm 3 , and 67% were prescribed antiretroviral therapy within the firs year of care. Compared with the 543 patients who were included in the analysis, the 24 patients who died within the firs year were more likely to have baseline CD4 + cell counts !200 cells/mm 3 ( ), lack private health insurance ( ), and belong to P ! .01 P ! .01 an HIV risk group other than men who have sex with men ( ; data not shown). P ! .01
Factors associated with missed visits within the fi st year of care. In unadjusted analyses, missed visits within the f rst year of HIV care were more common among younger patients, female patients, black patients, HIV risk groups other than men who have sex with men, patients lacking private health insurance, and patients with substance abuse disorders (table 2). In multivariable logistic regression analysis, missed visits were associated with younger age (OR, 0.81 per 10 years of age, 95% CI, 0.66-0.99 per 10 years of age), black race (OR, 2.74; 95% CI, 1.77-4.23), and having public health insurance (OR, 2.09; 95% CI, 1.10-3.96); they were inversely associated with a baseline CD4 + cell count of 200-350 cells/mm 3 (vs. у350 cells/ mm 3 ; OR, 0.59; 95% CI, 0.37-0.92) (table 2). Propensity scores for missed visits were determined for each study participant ). Only those P ! .05 missed visits for which patients did not notify the clinic in advance that they would not attend their appointment were included in this measure ("no show" visits). Appointments cancelled by a patient in advance, those scheduled while a patient was hospitalized, and those cancelled by the clinic were not included in the missed visit measure.
a Multivariable logistic regression model characteristics with a Hosmer-Lemeshow goodness-of-fit P value of . 19 (table 3) . Sensitivity analysis using propensity score methods yielded fin ings similar to those obtained by the primary analysis, with missed visits during the firs year of care increasing the hazards of long-term mortality (HR, 2.52; 95% CI, 1.15-5.52) while controlling for propensity for a missed visit and receipt of antiretroviral therapy (table 3) .
DISCUSSION
Missed primary HIV care visits in the year after establishing initial outpatient treatment were associated with subsequent mortality, even when controlling for baseline CD4 + cell count and receipt of antiretroviral therapy within the firs year. Mortality rates were 12 times higher for patients with missed visits, compared with mortality rates for patients who attended all scheduled appointments during the firs year of care (2.3 vs. 1.0 deaths per 100 patient-years of follow-up; ). Al-P p .02 though a modest absolute difference in mortality rate was observed, these finding may have profound public health implications. Because tens of thousands of patients with newly diagnosed infection require linkage to HIV care in the United States annually [22] , extrapolation of our finding to the level of the general population results in considerable mortality, particularly in light of the high proportion of patients who miss visits shortly after establishing outpatient HIV treatment [7, 12] .
We posit that missed visits during the firs year of care are not causally responsible for reduced long-term survival but, rather, may identify a subset of patients whose health behaviors portend increased mortality. We speculate that worse subsequent retention in care and lower antiretroviral medication adherence among those with missed visits ultimately places them at increased risk of death. Accordingly, missed visits in patients establishing initial outpatient treatment may serve as a marker in identifying individuals at risk for poor future health outcomes.
The current study advances earlier research by focusing on patients who are establishing an initial linkage to outpatient HIV treatment, which is a vulnerable population that has not been well evaluated previously and is expected to increase dramatically in coming years [8, 9] . Studies assessing survival among patients with HIV infection typically focus on individ-uals who are initiating antiretroviral therapy or who are participating in ongoing cohort studies [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] . Many new patients miss appointments and/or are lost to follow-up shortly after attending an initial clinic visit, and they often fail to initiate antiretroviral therapy as a result [7, 12, 13] . Furthermore, antiretroviral medications may not be indicated in patients who are establishing care based on baseline CD4 + cell counts and plasma HIV RNA levels [33] . Among our sample, one-third of patients did not receive antiretroviral therapy within the f rst year of outpatient HIV treatment, which is a group that would not have been evaluated if the current study employed inclusion criteria that were based on initiation of antiretroviral therapy. Therefore, the evaluation of missed visits and other factors associated with survival among patients who initiate outpatient HIV care complements earlier research and provides novel insight into an understudied group. Our findin that 60% of patients missed at least 1 visit within the firs year of care underscores the importance of the higher observed mortality in this group. These results can be applied in clinical practice to identify a priority population and to inform the development of focused interventions designed to improve long-term survival in new patients initiating outpatient HIV treatment.
Similar to the association observed in this study between missed visits and mortality in patients who are establishing HIV care, a relationship was recently reported between retention in care and survival among patients starting antiretroviral therapy [23, 30] . In a study of HIV-infected male patients who received treatment through the US Department of Veterans Affairs system, Giordano et al. [23] also found a significan relationship between retention in care and antiretroviral medication ad- NOTE. Data in bold are statistically significant ( ). P ! .05 a In the primary analysis, the Cox proportional hazards model (i.e., multivariable hazard ratio) includes the variables listed in the table (age, sex, race, HIV infection risk factor, health insurance, affective mental health disorder, substance abuse, alcohol abuse, baseline CD4 + cell count, baseline viral load, missed visit status during the first year of treatment, and antiretroviral therapy receipt within the first year of treatment). In the sensitivity analysis, the Cox proportional hazards model includes missed visit status during the first year of treatment, propensity score for missed visit during the first year of treatment (derived from the multivariable logistic regression model in table 2, which included age, sex, race, HIV infection risk factor, health insurance, affective mental health disorder, substance abuse, alcohol abuse, baseline CD4 + cell count, and baseline viral load), and antiretroviral therapy receipt within the first year of treatment.
herence, supporting our hypothesis that missed visits may identify patients who are at risk for worse outcomes during subsequent care.
In addition to those individuals with missed outpatient appointments, older patients and those with more-advanced HIV infection when establishing outpatient treatment had higher mortality rates in our study. These finding are important, because older patients account for an increasing proportion of patients with newly diagnosed infection who are establishing HIV care [22] . In addition, recent studies have found that 150% of patients with newly diagnosed HIV infection who present for initial care have baseline CD4 + cell counts that are !200 cells/mm 3 [3] [4] [5] [6] , which is a characteristic that was associated with higher rates of observed mortality in our study. Part of the rationale behind the updated CDC HIV testing recom-mendations is the desire to facilitate earlier diagnosis of HIV infection and linkage to HIV care before progression to advanced disease [1] . Our study suggests that there may be longterm benefit to patient survival if these recommendations are successfully implemented and result in improved timeliness of HIV infection diagnosis. Accordingly, our finding provide empirical evidence to support the CDC HIV testing recommendations and may serve as a call to action for health care providers.
Of note, receipt of antiretroviral therapy during the fi st year of care was not associated with subsequent mortality. After antiretroviral treatment initiation, continuous receipt of medication is necessary to achieve optimal clinical outcomes. Importantly, initial receipt of antiretroviral medication does not necessarily translate to subsequent long-term treatment; pa-Downloaded from https://academic.oup.com/cid/article-abstract/48/2/248/306150 by guest on 30 January 2020 tients are often lost to follow-up after establishing HIV care [7, 12, 13] . It is possible that patients with missed visits within the firs year of HIV care had worse subsequent retention and resultant poor longitudinal receipt of and adherence to antiretroviral medications, which contributed to the higher observed long-term mortality in this group.
Our study also contributes additional knowledge regarding engagement in care among HIV-infected individuals, which is an area of growing interest [34] . In this study, there were strong associations between missed visits and younger age, black race, and public health insurance. Previously, we found that these sociodemographic groups were less likely to attend an initial clinic visit and establish care at our treatment center after calling to schedule an appointment [15] . Similarly, others have reported that missed visits were more common in these groups, which bear a growing and disproportionate burden of the US HIV infection epidemic [17, 18, 22, 35] .
Formative research is needed to better understand the barriers and facilitators of clinic attendance and use of services, such that informed interventions may be developed to improve the initial linkage and subsequent retention of infected individuals in outpatient HIV care. Case management and patient navigation models hold promise and may link patients with community resources and provide social support, as well as foster problem-solving skills and build self-effi acy through strength-based approaches that enable patients to remain better engaged in care [11, 36] . The impact of these interventions on long-term survival remains to be seen. Successful interventions may have important implications not only for individual patients but also for public health and secondary HIV infection prevention efforts. Patients who are engaged in treatment may benefi from prevention messages and reduce their risk transmission behaviors [37] . In addition, the reduction of plasma HIV RNA levels in response to antiretroviral therapy may reduce sexual transmission among patients engaging in risk behaviors [38, 39] . Receipt of prevention messages and antiretroviral therapy is contingent on linkage to and retention in outpatient HIV treatment services after diagnosis, which highlights the vital role played by engagement in care [34] .
The finding of our study should be interpreted with respect to the limitations of the current analyses. As with all observational studies, we are able to identify associations but cannot attribute causality, and there is the potential for unmeasured confounding. Our study was conducted at a single center in the southeastern United States, and therefore, our fi dings may not be generalizable to other regions of the country or to different patient populations. However, our patient population is largely reflectiv of the sociodemographic composition of the national HIV epidemic [22] . Mental health, substance abuse, and alcohol abuse disorders were recorded from diagnosis lists in the medical record and were not determined using validated instruments. These comorbid conditions may be underrecognized in clinical practice. Mortality was ascertained by query of the Social Security Death Index, which may experience reporting delays from time of death to entry in the database. However, we have no reason to believe that delayed reporting should differentially impact individuals on the basis of appointment attendance within the firs year of care. Accordingly, we do not feel that this introduced a systematic bias that impacted our f ndings or their interpretation.
In conclusion, patients with missed visits in the year after establishing initial outpatient HIV care had more than twice the rate of subsequent mortality, compared with patients who did not miss visits, even when controlling for baseline CD4 + cell count and antiretroviral receipt within the firs year. These finding are particularly relevant in light of revised CDC HIV testing recommendations and the anticipated large increase in patients with newly diagnosed infection who will require linkage to HIV care in the coming years [1, 8, 9] . Future research is needed to identify barriers and facilitators to initial connection and early retention in HIV care, such that informed interventions can be developed to ensure that individuals derive maximal benefit from the tremendous recent advances in the treatment of HIV infection.
